Sasha Jovanovic
4 min read
Procter & Gamble stock ripped higher today, jumping 5.6% to US$165.59 after its Q1 2027 update hit the tape. The market reacted quickly, but the real story sits inside the income statement. Core earnings per share came in at US$2.00 on revenue of US$23.3b, numbers that matter less for the one day pop and more for what they indicate about the profit engine behind this premium household products giant.
Like the way Procter & Gamble turns steady revenue into earnings but want a wider set of cash generative consumer staples to compare it against? Check out the list of solid balance sheet and fundamentals stocks (26 results)
Q1 2027 Earnings Summary
-
Revenue (Q1 2027 vs. Q1 2026): US$23,276m vs. US$22,386m (up about 4.0%)
-
Net Income, Excl. Extra Items (Q1 2027 vs. Q1 2026): US$4,731m vs. US$4,677m (roughly flat, up about 1.2%)
-
Basic EPS (Q1 2027 vs. Q1 2026): US$2.00 vs. US$2.00 (flat, 0.0%)
-
Organic Sales Growth (Q1 2027 vs. Q1 2026): +4.0%, with volume contributing 2.4 percentage points, pricing contributing 0.4 percentage points, and mix contributing a little over 1 percentage point
Earnings tell you how Q1 landed, but cash flows tell you how Procter & Gamble funds dividends, reinvestment, and the balance sheet over time. Investors who care about valuation usually start with those cash streams, not a single quarter.
On Procter & Gamble’s recent cash flows alone, and using a discounted cash flow lens, the stock could be a meaningful 22% undervalued.
Procter & Gamble: Moat Story Meets Q1 Reality
Fans of the Procter & Gamble moat story argue that pricing power and disciplined capital use keep this machine compounding.
“Procter & Gamble operates within a very competitive environment. However, its higher operating margins and wide moat its a clear sign it still operates with competitive advantages over its competitors as well as it has the capability of raising prices if needed.”
Q1 organic sales grew 4.0%, with volume doing most of the work and pricing adding 0.4 points. That mix hints at real consumer pull rather than reliance on list hikes. Core EPS held at US$2.00 and management plans about US$15b of FY27 cash returns, which is consistent with the claimed capital discipline.
Testing Margin Pressure Fears Against Current Print
The bear worry is that competition and maturity slowly chip away at Procter & Gamble’s profitability and growth runway.
“Despite this, I feel the future for this company still holds some friction by the appearance of fierce competition, pressuring Procter & Gamble to reduce its prices and by consequence its operating margins. Also, unless something exceptional happens, given the maturity of the business, I see its revenues grow below or at the economy growth rate.”
